Home>IPO>Krishna Institute of Medical Sciences Limited IPO

KIMS IPO

Krishna Institute of Medical Sciences Limited IPO

₹14,670 /18 sharesMinimum Investment

IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
BSE & NSE₹825₹1,009+ ₹184 (22.3%)

IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
16 Jun - 18 Jun ‘21₹14,67018₹815 - ₹825
Issue SizeIPO Doc
2143.74 Cr
RHP PDFopen_in_new

Subscription Rate As on 18th Jun 2021, 4:50 PM

  • Retail Individual Investor
    2.89x
  • Non-Institutional Investor
    1.89x
  • Qualified Institutional Buyers
    5.26x
  • Employees
    1.06x

About Company

Krishna Institute of Medical Sciences Ltd. is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered. It provides multi-disciplinary integrated healthcare services, with a focus on primary, secondary, and tertiary care in Tier 2-3 cities and primary, secondary, tertiary, and quaternary healthcare in Tier 1 cities. KIMS operates nine multi-specialty hospitals under the “KIMS Hospitals” brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021. This is 2.2 times more beds than the second-largest provider in Andhra Pradesh and Telangana. The range of healthcare services offered is spread across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopedics, organ transplantation, renal sciences, and mother & child care
... Read More

Strengths & Risks

  • add
    One of the largest corporate healthcare groups in Telangana and Andhra Pradesh.
  • add
    Well-positioned to consolidate in India’s large, unorganized yet rapidly growing and underserved affordable healthcare market.
  • add
    Ability to attract, train and retain high-quality doctors, consultants, and medical support staff.
  • add
    Track record of strong operational and financial performance.
  • add
    Successful history of sourcing, executing and integrating acquisitions.
  • add
    Experienced senior management team with strong institutional shareholder support.
  • remove
    Dependence on its healthcare professionals, including doctors that KIMS engages on a consultancy basis.
  • remove
    COVID-19 pandemic and other health concerns that may impact regular business operations.
  • remove
    Dependence on hospitals in Hyderabad and certain specialties.
  • remove
    Hospitals built on leased land and inability to renew the lease for any reason.
  • remove
    Impact of short-term and long-term borrowings.
  • remove
    Inability to comply with applicable safety, health, environmental, and other governmental regulations.
  • remove
    Inability to effectively estimate, price, and manage its healthcare costs can affect operations.
  • remove
    Inability to maintain bed occupancy rates at sufficient levels may impact business.
  • remove
    Inability to keep pace with technological changes, new equipment & service introductions, changes in patients' needs, and evolving industry standards.
  • remove
    Dependence on payments from patients, insurers, and other payers.
  • remove
    Risk of legal claims and regulatory actions arising out of the medical services provided by KIMS.
  • remove
    Failure of third-party suppliers and manufacturers to provide supplies and equipment on time.
  • remove
    Risks relating to the handling of personal information, including medical data.

Financials

*All values are in Rs. Cr
No Graph Data To Display
ⓒ 2016-2021 Groww. All rights reserved, Built with in India
ABOUT GROWW
keyboard_arrow_down